Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis in vivo via suppression of TNF-α expression in macrophages

Overview of attention for article published in Frontiers in endocrinology, September 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,171 followers.

RT @FrontEndocrinol: New Research: Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis in vivo via suppressio…

18 Sep 2023

Reply Repost Favourite

New Research: Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis in vivo via suppression of TNF-α expression in macrophages: Introduction Hypertension is a major risk factor for cardiovascular disease… #Endocrinology #Endo h

18 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.